Technology

Will the UK learn from past efforts to champion innovation in the NHS? Leela Barham assesses the Phase 1 evaluation of its Innovation, Health and Wealth initiative.

Pfizer and Calibr in Heart Failure Research Collaboration

January 14th 2016

January 14, 2016.

Wave of Healthcare M&A to Continue in 2016, says Survey

January 13th 2016

January 13, 2016.

Parkinson's Disease Treatment Pipeline "Highly Active", Says Report

January 12th 2016

January 12, 2016.

FDA Violation Letters at All-Time Low in 2015

January 11th 2016

January 2011, 2016.

Shire to Buy Baxalta for $32 Billion

January 11th 2016

January 11, 2016.

Toward JP Morgan 2016: Pharm Exec's Top Tweets

ByCasey McDonald

January 8th 2016

January 08, 2016.

FDA: More “Me-Betters” and Focused Breakthroughs

ByJill Wechsler, Pharm Exec’s Washington Correspondent

January 7th 2016

January 05, 2016.

Priority Review Vouchers Raise Risks, say FDA Officials

ByJill Wechsler, Pharm Exec’s Washington Correspondent

January 6th 2016

January 06, 2016.

mAbs to Watch in 2016

ByRandi Hernandez

January 5th 2016

January 05, 2016.

Global Breast Cancer Treatment Market to Reach $17.2 Billion by 2021

January 5th 2016

January 05, 2016.

Pfizer Depression Candidate Fails in Phase 3 Study

January 4th 2016

January 04, 2016.

UK Cancer Drug Discovery Database Goes 3D

January 4th 2016

January 04, 2016.

KaloBios Files for Bankruptcy Following Shkreli Arrest

January 4th 2016

January 04, 2016.

FDA Grants Priority Review Status to Cholera Vaccine

December 23rd 2015

December 23, 2015.

EMA Spells Out Plan for Trial Portal and Database

ByApplied Clinical Trials

December 23rd 2015

December 23, 2015.

Gastric Cancer Treatment Market to Expand Rapidly to $4.4 Billion by 2024

December 22nd 2015

December 22, 2015.

Lilly Slaps $8,000-Per-Treatment-Cycle Price Tag On Lung Cancer Drug

December 21st 2015

December 21, 2015.

Turing Announces Shkreli Resignation, Appoints Interim CEO

December 21st 2015

December 21, 2015.

Retrophin Issues Statement on Indictment of Martin Shkreli

December 18th 2015

December 18, 2015.

Technology

Latest News

Small Cell Lung Cancer Treatment Market "Will Escalate to $2.29 Billion by 2024"

Regen BioPharma and NIH in Cancer Research Collaboration

Italy's Money-Back Guarantee for Cancer Treatments

Hodgkin’s Lymphoma Treatment Market "Set to Quadruple to $1.4 Billion by 2024"

European Injectable Drug Delivery Market to Reach $207.3 Billion by 2020

UK NHS: Evaluating Innovation, Health and Wealth

Pfizer and Calibr in Heart Failure Research Collaboration

Wave of Healthcare M&A to Continue in 2016, says Survey

Parkinson's Disease Treatment Pipeline "Highly Active", Says Report

FDA Violation Letters at All-Time Low in 2015

Shire to Buy Baxalta for $32 Billion

Toward JP Morgan 2016: Pharm Exec's Top Tweets

FDA: More “Me-Betters” and Focused Breakthroughs

Priority Review Vouchers Raise Risks, say FDA Officials

mAbs to Watch in 2016

Global Breast Cancer Treatment Market to Reach $17.2 Billion by 2021

Pfizer Depression Candidate Fails in Phase 3 Study

UK Cancer Drug Discovery Database Goes 3D

KaloBios Files for Bankruptcy Following Shkreli Arrest

FDA Grants Priority Review Status to Cholera Vaccine

EMA Spells Out Plan for Trial Portal and Database

Gastric Cancer Treatment Market to Expand Rapidly to $4.4 Billion by 2024

Lilly Slaps $8,000-Per-Treatment-Cycle Price Tag On Lung Cancer Drug

Turing Announces Shkreli Resignation, Appoints Interim CEO

Retrophin Issues Statement on Indictment of Martin Shkreli

Trending on PharmExec

Johnson and Johnson Reveals Plan to Separate Orthopaedics Business

The Most-Favored-Nation Policy: Outlook and Implications Beyond U.S.

Nabla Bio Enters $1 Billion Multi-Year Research Collaboration with Takeda

The Evolving Landscape in Psychiatry: Challenges and Opportunities for Biopharma

Pharma Companies Shift Towards Direct-To-Consumer Sales in US Amidst Tariff and Pricing Turmoil